Coral has been promoted for many years as a potentially ideal bone graft substitute, able to assist in the healing of bone defects and traumas. In the past coral has not been entirely reliable due to variable strength, porosity and resorbtion time. Zoan Biomed has solved this problem by growing clonally identical corals in tightly controlled conditions and selecting species of optimal properties for particular bone grafting applications. The innovation associate project was designed to further enhance the potential for coral in biomedical applications by investigating the combination of coral skeleton material with other materials to produce printable ‘inks’ for 3D printing into new structures and forms to target new areas of treatment, including spinal or cartilage healing applications. By developing new composite biomaterials this project contributes to the rapid evolution of medical treatments currently occurring at the interface between biology, engineering and computing (‘bioconvergence’). By partnering with world-leading bioconvergence company Cellink (Bico group) as a result of the work of the Innovation Assocaite, Zoan’s contribution to the current biomedical revolution has been enhanced and new biomaterials are being developed during and beyond the lifetime of this project.
The overall objectives of the proposal were to i) explore the potential of 3D printing of coral as a future product line for the compant; ii) to develop an innovation plan around this potential ; iii) to build new partnerships for Zoan and jointly develop concepts for future projects and iv) to support the career development of the innovation associate. The project has succeeded and exceeded all of these objectives, with printing and initial evaluation of the world’s first coral bioink achieved, partnership agreement and joint patents achieved with Cellink and iii) a permanent position for the innovation associate as Head of R+D for the company.
The project is the springboard for a whole new commercial avenue for Zoan and significant impact in biomedicine and beyond.